
BREAKING NEWS: Data Released from Anetumab Ravtansine Study
Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY
MESOTHELIOMA NEWS
Scroll to find news of interest to you, or search by category. The Mesothelioma Applied Research Foundation covers mesothelioma news for patients and their families. Our write-ups are heavily reliant on peer-reviewed medical research studies with input from mesothelioma experts from around the world but are also accessible to non-medical readers.
Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY
In part one and part two of the situational awareness blog series, we defined situational awareness and referenced its use in do-it-yourself projects. In this
The Meso Foundation congratulates Dr. Harvey Pass for receiving the Merit Award from the International Association for the Study of Lung Cancer (IASLC). Dr. Pass
If you attended our International Symposium on Malignant Mesothelioma in March of this year, you may recall the buzz of excitement that coursed throughout the
Over the last several year or so, a number of people have posted information about various supplements they favor, both for general health and, occasionally,
We have recently announced that we will be holding a telephone workshop about organizing your own fundraising event for mesothelioma. If you ever thought about
“Do it yourself” (DIY) projects are those that you undertake on your own without the help of experienced professionals. Commonly, a DIY project may include
Last week, we announced the important news that Congressman Katko introduced in Congress a bill to create a mesothelioma registry. You can read the full
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!